microdose oral glp 1 GLP-1 – näky Microdosing GLP-1: A Science-Backed Path

This is the question I get most, so let me be very clear

In fact, one study showed that people who discontinued Wegovy (another GLP-1) regained 65% of the weight they had lost within less than a year

The delivery method is fundamentally flawed

FDA-approved GLP-1 medications are administered via subcutaneous injection (semaglutide, liraglutide, dulaglutide, tirzepatide) into the abdomen, thigh, or upper arm, or taken orally as Rybelsus

The studied dosing starts low (about 2 mg weekly) and is increased roughly every four weeks to a target dose, with 12 mg being the highest dose in the main Phase 2 obesity trial

Next, find your BMI on the chart below to see if youre within the indicated range for GLP-1 treatment: *The above chart is not meant for medical diagnosis purposes